These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21857334)

  • 21. [Long term virologic efficacy of antiretroviral agents].
    Lang JM
    Med Mal Infect; 2006 Jul; 36 Suppl 2():S206-11. PubMed ID: 17075998
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anaesthesia and intensive care characteristics in HIV-infected pregnant patients receiving the antiretroviral therapy].
    Krugova LV; Vartanov VIa; Vartanova IV; Shakhovskaia IN; Khutorskaia NN; Lapteva IV
    Anesteziol Reanimatol; 2010; (6):32-6. PubMed ID: 21400795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
    Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
    Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study confirms effectiveness of antiretroviral drugs for HIV patients.
    Hagmann M
    Bull World Health Organ; 2003; 81(12):918-9. PubMed ID: 14997251
    [No Abstract]   [Full Text] [Related]  

  • 25. Protecting the next generation--eliminating perinatal HIV-1 infection.
    Mofenson LM
    N Engl J Med; 2010 Jun; 362(24):2316-8. PubMed ID: 20554987
    [No Abstract]   [Full Text] [Related]  

  • 26. HIV drug resistance and mother-to-child transmission of HIV.
    Weidle PJ; Nesheim S
    Clin Perinatol; 2010 Dec; 37(4):825-42, x. PubMed ID: 21078453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of interventions in improving adherence to antiretroviral therapy.
    Côté JK; Godin G
    Int J STD AIDS; 2005 May; 16(5):335-43. PubMed ID: 15949060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
    Waweru C
    N Engl J Med; 2008 Oct; 359(17):1845-6; author reply 1846-7. PubMed ID: 18949839
    [No Abstract]   [Full Text] [Related]  

  • 29. Raltegravir-based highly active antiretroviral therapy has beneficial effects on the renal function of human immunodeficiency virus-infected patients after solid organ transplantation.
    Moreno A; Pérez-Elías MJ; Casado JL; Fortún J; Bárcena R; Quereda C; Del Campo S; Gutiérrez C; Pastor O; Nuño J; Fernandez A; Moreno S
    Liver Transpl; 2010 Apr; 16(4):530-2. PubMed ID: 20213666
    [No Abstract]   [Full Text] [Related]  

  • 30. The long-term consequences of antiretroviral therapy.
    Smith D
    J HIV Ther; 2006 Jun; 11(2):24-5. PubMed ID: 16981592
    [No Abstract]   [Full Text] [Related]  

  • 31. Darunavir: after multiple antiretroviral treatment failure: another option.
    Prescrire Int; 2008 Jun; 17(95):109. PubMed ID: 18629967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cohort profile: the Swiss HIV Cohort study.
    ; Schoeni-Affolter F; Ledergerber B; Rickenbach M; Rudin C; Günthard HF; Telenti A; Furrer H; Yerly S; Francioli P
    Int J Epidemiol; 2010 Oct; 39(5):1179-89. PubMed ID: 19948780
    [No Abstract]   [Full Text] [Related]  

  • 33. Preface. Perinatal HIV infection.
    Kourtis AP; Bulterys M
    Clin Perinatol; 2010 Dec; 37(4):xix-xxi. PubMed ID: 21078443
    [No Abstract]   [Full Text] [Related]  

  • 34. The long-term consequences of antiretroviral therapy: a review.
    Boyd M; Reiss P
    J HIV Ther; 2006 Jun; 11(2):26-35. PubMed ID: 16981593
    [No Abstract]   [Full Text] [Related]  

  • 35. Preventing perinatal transmission of HIV: your vigilance can pay off.
    Tolle MA
    J Fam Pract; 2010 Mar; 59(3):E1. PubMed ID: 20230730
    [No Abstract]   [Full Text] [Related]  

  • 36. Antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.
    Mills J
    N Engl J Med; 2008 Oct; 359(17):1846; author reply 1846-7. PubMed ID: 18949841
    [No Abstract]   [Full Text] [Related]  

  • 37. Biomedical methods for HIV prevention: new setbacks.
    Laurence J
    AIDS Read; 2008 Apr; 18(4):163-4. PubMed ID: 18472438
    [No Abstract]   [Full Text] [Related]  

  • 38. [AIDS and a new microbicidal gel].
    Nau JY
    Rev Med Suisse; 2010 Aug; 6(259):1562-3. PubMed ID: 20873439
    [No Abstract]   [Full Text] [Related]  

  • 39. Atazanavir (Reyataz) and emtricitabine (Emtriva) for HIV infection.
    Med Lett Drugs Ther; 2003 Nov; 45(1169):90-2. PubMed ID: 14603099
    [No Abstract]   [Full Text] [Related]  

  • 40. Predicting and monitoring antiretroviral adherence.
    Gross R
    LDI Issue Brief; 2007; 13(2):1-4. PubMed ID: 18354853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.